Rabies (Healthy Volunteers)

Healthy/Normal·MeSH: Rabies

Prevalence

0.1 / 100K

13 drugs in development·4 companies·6 clinical trials

Drug Pipeline by Phase

Phase 3(10)

Drug	Company
booster vaccination	Prime Medicine, Inc. (PRME)
equine rabies immunoglobulins	Sanofi (SNY)
human diploid cell vaccine	Sanofi (SNY)
human rabies immunoglobulins	Sanofi (SNY)
purified inactivated rabies vaccine	Sanofi (SNY)
purified vero rabies vaccine - serum free	Sanofi (SNY)
purified vero rabies vaccine - serum free vrvg-2	Sanofi (SNY)
rabies immune globulin	Sanofi (SNY)
Sinovac rabies vaccine	Crinetics Pharmaceuticals, Inc. (CRNX)
vrvg-2	Sanofi (SNY)

Phase 2(3)

Drug	Company
human rabies immunoglobulin	CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (CBPO)
rabies vaccine	CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (CBPO)
recombinant human rabies virus monoclonal antibody	CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. (CBPO)

BioSniper tracks 13 drugs in development for Rabies (Healthy Volunteers) across 4 companies.

There are 6 clinical trials targeting Rabies (Healthy Volunteers) tracked by BioSniper.

The estimated prevalence of Rabies (Healthy Volunteers) is approximately 0.1 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.